News – Page 39 – PROSTATE WARRIORS – The latest news about prostate cancer

In Vitro: Targeted Cancer Therapy with 4armPEG-DD: A Precision Approach for Prostate Cancer

October 30, 2024/0 Comments/in Delivery, Preclinical Research/by Max

In vivo: Menadione Sodium Bisulfite (vitamin K3) as a Pro-Oxidant Therapy for Prostate Cancer

October 30, 2024/0 Comments/in Preclinical Research/by Max

Post-hoc of ARASENS for metastatic hormone sensitive prostate cancer

October 30, 2024/0 Comments/in Clinical Trial, Metastatic, Phase 3/by Max

Darolutamide Plus ADT and Docetaxel Extends Survival in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk in ARASENS Trial

October 29, 2024/0 Comments/in Clinical Trial, Metastatic, Phase 3/by Max

ARX517 Achieves Key Safety and Efficacy Milestones in Phase 1/2 Trials for Metastatic Castration-Resistant Prostate Cancer

October 29, 2024/0 Comments/in Clinical Trial, Metastatic, Phase 1/by Max

Darolutamide Plus ADT: A Great Treatment Option for Metastatic Hormone-Sensitive Prostate Cancer

September 30, 2024/0 Comments/in Clinical Trial, Metastatic, Phase 3/by Max

First-in-Class Targeted microRNA Therapy Slows Cancer Tumor Growth

September 29, 2023/0 Comments/in Preclinical Research/by Max